Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00782210
Show Display Options
Rank Status Study
1 Completed
Has Results
12 / 48 Week Pivotal PFT vs PBO in COPD I
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Olodaterol (BI1744);   Drug: placebo

Indicates status has not been verified in more than two years